جست‌وجوی استاد و پژوهشگر

Bradi Bartrug Grangerمشاهده پروفایل

استاد پژوهشی

• Nursing Research
• Health Policy
• Cardiovascular Medicine
• +۵ مورد دیگر

Bradi Bartrug Granger is a Research Professor at Duke University School of Nursing, Director of the Duke Heart Center Nursing Research Program, and adjunct faculty at the University of Gothenburg. She holds core faculty status at the Duke-Margolis Center for Health Policy. With doctorate in nursing from the University of North Carolina at Chapel Hill, an MSN from Duke University, and a BSN from the University of Tennessee at Knoxville, her expertise spans implementation science, heart failure care, workforce stability, hypertension management, and health equity. 2004 - Ph.D., University of North Carolina at Chapel Hill 1991 - M.S.N., Duke University 1988 - B.S.N., University of Tennessee at Knoxville Her recent publications focus on nurse retention strategies, virtual reality rehabilitation for ICU patients, hypertension control in Black populations, and palliative care integration in heart failure management. Key grants include NIH/NINR-funded Nurse LEADS program (2024-2029), NSF research on XR rehabilitation games (2025-2027), and NHLBI-funded urine output tracking studies (2024-2026). She actively promotes evidence-based practice through clinical decision support tools and workforce analytics, maintaining affiliations with Duke's Science & Society initiative and Margolis Center for Health Policy.

Yvonne Linمشاهده پروفایل

دانشیار

• Pharmacokinetics
• Pharmacogenomics
• Drug Metabolism
• +۷ مورد دیگر

Dr. Yvonne Lin serves as Assistant Dean for Academic Affairs and Associate Professor within the Department of Pharmaceutics at the University of Washington School of Pharmacy. Her academic appointments span multiple units including the Obstetric-fetal Pharmacology Research Unit (OPRU) and Pharmaceutics Faculty. She maintains active research and teaching roles while providing academic leadership across the institution. Dr. Lin's educational background includes a BA in Biophysics from the University of California at Berkeley and a PhD in Pharmaceutical Sciences from the University of Washington. She completed postdoctoral training at St. Jude Children's Research Hospital, establishing her foundation in pediatric pharmacology and drug metabolism. Her research program focuses on pharmacokinetics and pharmacogenomics with particular emphasis on natural product-drug interactions and the regulation of drug metabolizing enzymes in vulnerable populations. Dr. Lin investigates enzyme regulation in children and pregnant women, exploring how developmental and physiological changes impact drug metabolism. Her work utilizes metabolomics approaches to discover endogenous biomarkers related to drug metabolism and transport, with significant contributions to understanding vitamin D pharmacokinetics and CYP enzyme function. Analysis of her recent publications reveals consistent focus on developmental pharmacology, particularly in pediatric and pregnancy populations. Her work bridges basic mechanistic studies with clinical applications, often examining special populations that are historically underrepresented in pharmacological research. The research demonstrates strong methodological diversity including in vitro systems, clinical pharmacokinetic studies, biomarker development, and physiologically based pharmacokinetic modeling. Dr. Lin actively teaches multiple courses including PHARBE 506, PHARBE 510, PCEUT 507, and PCEUT 537. She serves as a research mentor with her laboratory accepting students, though specific advisees are not listed in available materials. Her research has received support through institutional resources including the Mass Spectrometry Center and Bioanalysis and Pharmacokinetics Lab. Her laboratory maintains focus on translational pharmacokinetic research with particular attention to vulnerable populations. Current work investigates drug metabolism in cystic fibrosis patients, vitamin D clearance mechanisms, and the impact of bariatric surgery on drug disposition. The research integrates pharmacogenomic, metabolomic, and clinical pharmacokinetic approaches to address critical gaps in therapeutic optimization for special populations.

Craig C. Malbonمشاهده پروفایل

استاد

• Signal Transduction
• Molecular Scaffold Biology
• Wnt Signaling Pathways
• +۶ مورد دیگر

Craig C. Malbon is a Leading Professor at Stony Brook University's School of Medicine, holding primary appointments in the Department of Pharmacological Sciences and secondary affiliation with the Department of Family, Population & Preventive Medicine. He directs an active research laboratory established in 1978 and serves as Director-emeritus of the NIH-funded Diabetes & Metabolic Diseases Research Program (1986-2015). Ph.D. in Pharmacology from Case Western Reserve University Postdoctoral training at Brown University and Harvard University M.Div. in Ethics from Union Theological Seminary Visiting Scholar at Princeton Theological Seminary His research focuses on signal transduction mechanisms in development and disease, specializing in molecular scaffold proteins (Dishevelleds and AKAPs) that organize signaling complexes. His laboratory employs advanced techniques including fluorescence correlation spectroscopy, proteomics, and live-cell imaging to study Wnt signaling and GPCR regulation. His 290+ publications reveal consistent emphasis on spatiotemporal aspects of cellular signaling with applications to cancer, metabolic disorders, and developmental biology. Recent work increasingly integrates his dual expertise through investigations into consciousness, moral formation, and bioethics failures . Recipient of the American Cancer Society Research Award (1997) Top 10 Researchers recognition (1990-2000) Goodman & Gilman Award from ASPET (2008) Fellow of AAAS (2008) Overseas Fellow, Royal Society of Medicine (2015) As an ethicist and ordained United Church of Christ minister, he directs bioethics training within NIH postdoctoral programs and has authored three books: Abortion in 21st Century America (2013), Assaulted Personhood (2021), and GUN-AMERICA (2022). His laboratory has trained over 75 doctoral students and 100 NIH fellows through the NIDDK-funded program, with alumni pursuing careers in academia, industry, and clinical research.

• Traumatic Brain Injury
• Pediatrics
• Balance
• +۵ مورد دیگر

Dr. Isabelle Gagnon is a Senior Scientist at the Research Institute of the McGill University Health Centre (RI-MUHC) and a Professor at the School of Physical and Occupational Therapy, Faculty of Medicine and Health Sciences, McGill University. She is affiliated with the Department of Pediatrics, Division of Emergency Medicine at McGill University Health Centre (MUHC), contributing to the Child Health and Human Development Program. Senior Scientist, RI-MUHC Professor, School of Physical and Occupational Therapy, McGill University Department of Pediatrics, MUHC Her research focuses on pediatric traumatic brain injury (TBI) and concussion , with emphasis on functional outcomes, rehabilitation interventions, and healthcare system impacts. Key domains include: Balanced assessment of motor and psychosocial domains Integration of imaging and virtual reality technologies Development of innovative rehabilitation approaches for slow recoverers Analysis of emergency department service organization on patient outcomes Recent publications (2024-2025) address quality indicators for trauma care , vestibulo-ocular reflex dynamics , direct-access physiotherapy models , and social determinants of health disparities . Her work spans clinical practice guidelines , EEG-based concussion biomarkers , and virtual pedestrian collision avoidance paradigms . Dr. Gagnon collaborates with interdisciplinary teams to advance pediatric concussion management , focusing on return-to-activity protocols and neurological data integration . She emphasizes patient-centered outcomes and healthcare accessibility .

• Psychopharmacology
• First Episode Psychosis
• Schizophrenia
• +۴ مورد دیگر

Dr. Howard Margolese is an Investigator at RI-MUHC and Associate Professor of Psychiatry at the Faculty of Medicine and Health Sciences, McGill University . His research focuses on psychopharmacology , first episode psychosis , and schizophrenia , with an emphasis on medication impacts and clinical trials. He has contributed extensively to understanding antipsychotic treatments, cognitive remediation, and the application of artificial intelligence in mental health . His work spans cross-cultural studies comparing mental healthcare outcomes in Montreal, Canada and Chennai, India , addressing trust in healthcare systems, functional outcomes, and treatment personalization. He has developed clinical decision support systems integrating AI for depression management and evaluated long-acting antipsychotic formulations. Key trends in his 81 publications include antipsychotic mechanisms , cognitive health strategies , and treatment switching protocols . His recent focus on AI-enabled decision systems highlights technological innovation in psychiatry. Despite his academic rigor, the text provides no details on scientific awards.

• health services
• medical education
• medical informatics
• +۴ مورد دیگر

Dr. Robyn Tamblyn is a Professor in the Department of Medicine, Division of Clinical Epidemiology at McGill University's Faculty of Medicine and Health Sciences. She serves as a Senior Scientist at the Research Institute of the McGill University Health Centre (RI-MUHC) within the Cardiovascular Health Across the Lifespan Program and the Centre for Outcomes Research and Evaluation (CORE). Dr. Tamblyn's research focuses on conducting observational and interventional studies in public health and health services delivery aimed at improving healthcare safety and quality. Her work centers on identifying modifiable determinants of adverse events and improved health outcomes through analysis of large linked clinical and administrative databases. She leads a research team that develops and evaluates computer-enabled interventions to address modifiable risk factors, including computerized decision-support systems, personal health record portals, self-management tools, and automated surveillance systems. Analysis of Dr. Tamblyn's publication record reveals a strong emphasis on medication safety, pharmacoepidemiology, and healthcare informatics. Her research spans multiple domains including medication adherence, inappropriate prescribing, deprescribing interventions, medication reconciliation, and the use of electronic health records for pharmacosurveillance. A notable trend in her work is the development and evaluation of technology-enabled interventions to improve medication management and reduce adverse drug events across various healthcare settings. As a Senior Scientist at RI-MUHC, Dr. Tamblyn leads research initiatives within the Centre for Outcomes Research and Evaluation, focusing on healthcare quality improvement and patient safety. Her work bridges clinical medicine, epidemiology, and health informatics to address critical gaps in healthcare delivery systems. She collaborates extensively with clinicians, pharmacists, and health services researchers to implement evidence-based interventions that directly impact patient care.

• Geriatrics
• Fall Prevention
• Frailty Assessment
• +۳ مورد دیگر

Natalie A. Sanders is an Associate Professor of Clinical Internal Medicine in the Division of Geriatrics at the University of Utah, specializing in faint, fall, and frailty syndromes with expertise in delirium prevention. She serves as Program Director for the ACGME-approved Geriatric Fellowship and will assume Medical Directorship of the University of Utah Madsen Geriatrics Clinic in July 2023, while maintaining clinical practice at the University of Utah Geriatrics Clinic and leadership in the Hospital Elder Life Program (HELP). Her educational journey includes: B.S. in Biological Sciences from the University of Nevada D.O. from Western University of Health Sciences Internal Medicine Internship, Residency, and Geriatrics Fellowship at University of Utah School of Medicine (serving as Chief Medical Resident) Dr. Sanders' research centers on geriatric syndromes, investigating baroreceptor function in fall pathogenesis, testosterone-exercise interventions for fracture prevention, and prognostic value of frailty assessments. She actively disseminates the Patients Priority Care framework to align clinical practice with patient-centered goals, supporting the University of Utah's Age Friendly Health System accreditation through evidence-based approaches to elder care. Her publication record (2011-2019) demonstrates consistent focus on fall prevention, frailty assessment, and cardiovascular-geriatric interfaces, with significant contributions to clinic model innovation, cost analysis of specialized geriatric services, and educational frameworks for interdisciplinary care. These works collectively advance the understanding of multifactorial geriatric syndromes through rigorous clinical investigation and practical implementation science. Her professional recognition includes: Fellow of the American College of Physicians (FACP) Dr. Sanders mentors medical students, residents, and geriatric fellows while co-leading the Medicine-Geriatrics integrated residency/fellowship program. Her leadership extends to the pioneering University of Utah Faint and Fall Clinic (where she expanded frailty assessments as Medical Director) and the HELP program, both critical to the institution's national recognition in age-friendly care. Current initiatives focus on scaling Patients Priority Care implementation and refining fall prevention protocols through multidisciplinary collaboration across clinical and academic units. She directs clinical operations for geriatric services at the Madsen Health Center while contributing to national geriatric education through American Geriatrics Society curricula, maintaining active roles in both clinical innovation and training the next generation of geriatric specialists.

Sarah Hillmanمشاهده پروفایل

دانشیار بالینی

• Women's Health
• Primary Care
• Menopause Research
• +۶ مورد دیگر

Sarah Hillman is an Associate Clinical Professor in Women's Health within the Applied Health Sciences department. She holds the prestigious 125th Anniversary Fellow designation and maintains an active research program focused on critical women's health issues across the lifespan, with particular emphasis on primary care contexts and patient experiences within the NHS. Her research profile demonstrates deep expertise in several key areas: Menopause care accessibility and women's experiences within contemporary healthcare systems Development of community-based care models following perinatal loss (stillbirth and second trimester miscarriage) Perineal trauma management and wound care pathways following childbirth Vaccination uptake among pregnant women Qualitative research methodologies and action research approaches Systematic reviews and meta-analyses in women's health Dr. Hillman's recent scholarly output shows remarkable productivity with 11 publications in 2025 alone, reflecting her leadership in translating research into practical clinical applications. Her work consistently employs patient-centered approaches to identify barriers to equitable care and develop evidence-based interventions that address real-world healthcare challenges. She has received recognition as a 125th Anniversary Fellow and her research has been published in high-impact journals including The British Journal of General Practice and BMJ Open. Her work has garnered attention from both academic (Mendeley readers) and professional (Bluesky) communities. Dr. Hillman currently leads three major NIHR-funded research projects through 2031, serves as Principal Investigator on a study examining HRT discontinuation, and mentors the next generation of researchers as she is accepting PhD students for projects in women's health and primary care. Her collaborative network spans multiple UK institutions and research specialties, reflecting the interdisciplinary nature of her work.

Colin Greavesمشاهده پروفایل

استاد

• Health Psychology
• Chronic Disease Prevention
• Behavioral Interventions
• +۷ مورد دیگر

Colin Greaves is a Chartered Health Psychologist and Professor of Psychology Applied to Health at the University of Birmingham. He specializes in developing and evaluating interventions for health behavior change, focusing on physical activity promotion, weight loss, smoking cessation, and chronic illness self-care. His work includes contributions to NICE and European diabetes prevention guidelines and a 5-year NIHR fellowship on weight loss maintenance. Academic Qualification: PhD in Psychology, University of Exeter (2003) Current funded research spans diabetes prevention (NDPS, ComPoD), heart failure self-management (REACH-HF), weight loss (SkiM), physical activity (REACT), and smoking cessation (TARS). His recent work emphasizes community-based trials, digital health applications, and co-designed interventions for musculoskeletal and post-bariatric care. Key Research Areas: Health behavior change interventions Chronic disease prevention Digital health tools (e.g., eMotion, Impulse Pal) Multimorbidity management Equity in healthcare access

• Biomedical Informatics
• Clinical Decision Support Systems
• Electronic Health Records (EHR) Analysis
• +۳ مورد دیگر

Hyung Paek, MD, MSEE, is a Lecturer in Biostatistics and Clinical Informatician at the Yale School of Public Health. His work bridges Biomedical Informatics with Emergency Medicine , focusing on Clinical Decision Support Systems and Health Equity in electronic health record (EHR) applications. Dr. Paek holds board certifications in Clinical Informatics and Internal Medicine , and his research explores Machine Learning for healthcare workforce predictions, Telehealth Equity for HIV patients, and Opioid Use Disorder interventions in emergency settings. MD, St. Louis University (1996) MSEE, Politechnic University (1986) Board Certified: Clinical Informatics (ABPM, 2017), Internal Medicine (ABIM, 2000) Dr. Paek's recent publications analyze EHR-Driven Predictive Models , Gender Productivity Gaps , and Telehealth Implementation during the pandemic. He frequently collaborates with Yale colleagues including Dr. Edward Melnick , Dr. Gail D'Onofrio , and Dr. James Dziura . His 2023 work in JAMA Network Open highlights emergency department buprenorphine adoption, while 2025 studies examine adaptive decision support systems for addiction treatment.

• Biostatistics
• Spatial Epidemiology
• Longitudinal Data Analysis
• +۵ مورد دیگر

Professor Peter Diggle is an EPSRC Senior Fellow at the University of Lancaster , where he leads a research program in Spatial and Longitudinal Data Analysis . He also holds an Adjunct Professor position in the Biostatistics Department at the Yale School of Public Health . Education : PhD from Newcastle University (1977), MSc from Oxford College (1973). Research Interests : Biostatistics, spatial epidemiology, longitudinal data analysis, public health modeling, and implementation science. Scientific Awards : EPSRC Senior Fellowship Recent Article Trends : His work spans geostatistical modeling for disease surveillance, wastewater-based COVID-19 monitoring, zoonotic spillover dynamics, and helminth control program optimization. Professional Roles : Founding co-editor of Biostatistics journal and trustee of the Biometrika Trust . Collaborations : Frequent collaborations with Federico Costa, Albert Ko, Jamie Childs, and Mitermayer Reis on tropical disease research.

Angelo P Tannaمشاهده پروفایل

استاد

• Glaucoma
• Ophthalmology
• Medical Imaging
• +۷ مورد دیگر

Angelo P Tanna, MD is Vice Chairman and Professor of Ophthalmology and Director of the Glaucoma Service at the Northwestern University Feinberg School of Medicine in Chicago, Illinois. He has served on the faculty since 1999, establishing himself as a leading expert in glaucoma diagnosis and treatment. Dr. Tanna holds multiple leadership positions including Chair of the American Academy of Ophthalmology's Basic and Clinical Science Course Glaucoma Committee. Dr. Tanna's research interests span several critical areas in ophthalmology, with a primary focus on glaucoma. His work encompasses the efficacy and safety of glaucoma medications, detection of glaucoma progression, and assessment of visual function in glaucoma patients. He has made significant contributions to understanding the impact of cataract on visual field testing in glaucoma and has developed new methods to detect visual field deterioration. His research also includes improving outcomes of incisional glaucoma surgery and innovative approaches using hydrogel polymers to prevent fibrosis after trabeculectomy. Analysis of Dr. Tanna's recent publications reveals a strong emphasis on applying advanced technologies to glaucoma management, including deep learning algorithms for visual field progression detection using OCT imaging. His work increasingly explores social determinants of health in glaucoma care, healthcare access disparities, and the relationship between systemic conditions and ocular health. The COAST clinical trial he leads represents a significant contribution to optimizing laser trabeculoplasty protocols for glaucoma treatment. Secretariat Award, American Academy of Ophthalmology (2019) Senior Achievement Award, American Academy of Ophthalmology (2017) Continuously listed in Best Doctors in America since 2005 Outstanding Teacher Award, Northwestern University Feinberg School of Medicine (2020) Multiple visiting professorships at leading institutions including Columbia University (2023) Dr. Tanna has served in various leadership roles in the American Glaucoma Society, including twice as a board member and as Chair (2010-2011). He currently chairs the American Academy of Ophthalmology's Basic and Clinical Science Course Glaucoma Committee and serves on editorial boards of prestigious journals including Ophthalmology and Survey of Ophthalmology. His COAST clinical trial investigates optimal selective laser trabeculoplasty protocols for treating glaucoma, potentially reshaping treatment guidelines. Dr. Tanna also leads research collaborations with biomedical engineers and geneticists, resulting in discoveries such as the association of ANGPT1 region SNPs with primary open-angle glaucoma.

Emily S. Gurleyمشاهده پروفایل

استاد

• Infectious Diseases
• Emerging Infections
• One Health
• +۴ مورد دیگر

Emily S. Gurley is a Professor at the Bloomberg School of Public Health , Johns Hopkins University . She holds primary affiliations with the Department of Epidemiology (Division of Infectious Disease Epidemiology) and Center for Global Health . Her work spans research, teaching, and field operations in Bangladesh , where she has led initiatives in outbreak detection and disease surveillance since 2003. Education: PhD, Johns Hopkins Bloomberg School of Public Health (2012) MPH, Emory University (2002) BA, Oglethorpe University (1996) Research Focus centers on emerging infectious diseases , particularly Nipah virus and arboviruses , using a One Health framework. She emphasizes disease surveillance , outbreak investigation , and transmission dynamics at the human-animal-environment interface. Her projects include CHAMPS (Child Health and Mortality Prevention Surveillance) in Bangladesh and collaborations with the US CDC . Notable Trends in Research include the intersection of zoonotic spillover , genomic epidemiology , and public health policy , with a focus on Bangladesh and South Asia . Her work addresses pandemic preparedness , vaccine trials , and antimicrobial resistance in low-resource settings. Scientific Awards include: Excellence in US COVID-19 Public Health Practice (Coursera, 2021) Coursera Innovation Award for Contact Tracing Course (2021) Shikani/El-Hibri Prize for Discovery (2020) Inaugural Abe Lilienfeld Student Award (2011) Advising and Collaborations highlight her mentorship of junior scientists and leadership in interdisciplinary studies. She serves on the WHO Nipah Virus Taskforce and contributes to global CHAMPS and Global Disease Detection programs.

Maoli Duanمشاهده پروفایل

دانشیار

• Otolaryngology
• Gene Therapy
• Stem Cell Therapy
• +۳ مورد دیگر

Maoli Duan is an Associate Professor and Senior Consultant at the Karolinska Institutet , affiliated with the Department of Clinical Science, Intervention and Technology under the Ear, Nose and Throat Diseases division. With over 150 peer-reviewed publications, his translational research bridges animal models and clinical applications in otolaryngology. Academic Rank: Associate Professor (Karolinska Institutet, 2006) Doctoral Degree: Department of Physiology and Pharmacology, Karolinska Institutet (1999) Research Focus Dr. Duan's work centers on gene therapy and stem cell treatments for sensorineural hearing loss , with recent breakthroughs in AAV vector delivery for congenital deafness. His 2025 Nature Medicine study demonstrated hearing restoration in patients with OTOF gene mutations through viral gene replacement. Publication Trends His 15 most recent articles (2023-2025) span biomedical engineering , clinical otology , and translational neuroscience . Key subfields include inner ear drug delivery , cochlear implants , gene therapy protocols , and viral vector optimization . Notably, his team has pioneered non-invasive approaches to treating Meniere's disease and noise-induced hearing loss . Collaborative Networks Dr. Duan collaborates with institutions across Europe , Asia , and North America , with recurring co-authors from Karolinska Institutet , University of Gothenburg , and Shanghai Jiao Tong University . His work appears in Nature Medicine , PNAS , and Advanced Science . Scientific Context Dr. Duan's research aligns with global efforts to address genetic hearing disorders through molecular interventions. His team's clinical trials demonstrate that gene therapy can restore near-normal hearing in OTOF mutation carriers without major adverse events, opening new pathways for non-invasive auditory restoration in both pediatric and adult populations.

Reidar Pedersenمشاهده پروفایل

استاد

• Medical Ethics
• Clinical Ethics Support
• End of Life Ethics
• +۱۰ مورد دیگر

Reidar Pedersen is a Professor at the Centre for Medical Ethics within the Institute of Health and Society at the University of Oslo. He has held significant leadership positions including Head of the Centre for Medical Ethics (2015-2023), Deputy Head of the Institute of Health and Society (2020-2023), and currently serves as Head of Research at the Institute since January 2024. His academic interests span medical ethics with particular focus on clinical ethics support, end-of-life ethics, informed consent, competence to consent, coercion, advance care planning, involvement of next of kin, resource allocation, health law and ethics, physician-patient communication, and hermeneutics. His research employs diverse methodologies including qualitative and quantitative approaches, intervention studies, systematic reviews, and theoretical analyses. Pedersen's recent publication record demonstrates consistent scholarly output with particular emphasis on implementation challenges of ethical frameworks in geriatric care, psychiatric settings, and pandemic response. His work shows a clear pattern of investigating how ethical principles translate into practical healthcare settings, with special attention to family involvement, patient autonomy, and organizational implementation barriers. His teaching activities are primarily directed toward healthcare personnel across various professions and specialties, covering most key topics within clinical ethics. He also teaches students at different academic levels and in various programs. As a scholar with dual training in medicine and philosophy, Pedersen brings an interdisciplinary perspective to medical ethics, bridging theoretical frameworks with practical healthcare applications. His leadership roles indicate significant institutional influence in shaping medical ethics research and practice in Norway.